Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.33 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 8/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21648645 | 0.85 | NAAA (0.44) | PRKCAKMT2ASMN1; SMN2 | |
| SCHEMBL24770415 | 0.85 | NAAA (0.44) | PRKCAKMT2ASMN1; SMN2 | |
| SCHEMBL24040348 | 0.85 | KMT2A (0.40) | EPHX2HDAC8KMT2A | |
| SCHEMBL22640969 | 0.83 | ALDH1A1 (0.42) | EPHX2KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL22272181 | 0.82 | HDAC3 (0.35) | HDAC8KMT2ASMN1; SMN2 | |
| SCHEMBL18768989 | 0.82 | KMT2A (0.33) | KMT2ASMN1; SMN2 | |
| SCHEMBL23919081 | 0.82 | — | — | |
| SCHEMBL18916449 | 0.81 | EPHX1 (0.40) | DDB1CRBNKMT2AALDH1A1 | |
| SCHEMBL22192126 | 0.81 | — | — | |
| SCHEMBL18867375 | 0.81 | KMT2A (0.32) | KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3321279-B1 | EXENATIDE MODIFIER AND USE THEREOF | BRIGHTGENE BIO MEDICAL TECH CO LTD (CN) | 2020-02-12 | — | — | EP | disclosed |
| EP-3321279-A1 | EXENATIDE MODIFIER AND USE THEREOF | Bright Gene Bio-Medical Technology Co., Ltd. (CN) | 2018-05-16 | — | — | EP | disclosed |